Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: SVP for Diagnostic Services of $DGX Sells 958 Shares

Automated

Patrick Plewman, the SVP for Diagnostic Services of $DGX, sold 958 shares of the company on 02-19-2026 for an estimated $196,227. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.7% of their shares of this class of stock. Following this trade, they now own 15,838 shares of this class of $DGX stock.

$DGX Insider Trading Activity

DGX Insider Trades

$DGX insiders have traded $DGX stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:

  • J. E. DAVIS (CEO and President) has made 0 purchases and 3 sales selling 55,093 shares for an estimated $10,589,759.
  • CATHERINE T. DOHERTY (EVP, Regional Businesses) has made 0 purchases and 6 sales selling 27,598 shares for an estimated $5,687,336.
  • MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 5 sales selling 29,801 shares for an estimated $5,596,313.
  • MARK E DELANEY (SVP & Chief Commercial Officer) sold 7,946 shares for an estimated $1,488,683
  • PATRICK PLEWMAN (SVP for Diagnostic Services) has made 0 purchases and 2 sales selling 6,620 shares for an estimated $1,351,275.
  • GARY M PFEIFFER sold 1,482 shares for an estimated $270,316
  • VICKY B GREGG sold 1,250 shares for an estimated $239,700

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DGX Hedge Fund Activity

We have seen 450 institutional investors add shares of $DGX stock to their portfolio, and 518 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$DGX Revenue

DGX Quarterly Revenue

$DGX had revenues of $2.8B in Q4 2025. This is an increase of 7.06% from the same period in the prior year.

You can track DGX financials on Quiver Quantitative's DGX stock page.

$DGX Congressional Stock Trading

Members of Congress have traded $DGX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $DGX stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$DGX Analyst Ratings

Wall Street analysts have issued reports on $DGX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Jefferies issued a "Buy" rating on 02/11/2026
  • Leerink Partners issued a "Outperform" rating on 10/21/2025
  • Mizuho issued a "Outperform" rating on 10/17/2025

To track analyst ratings and price targets for $DGX, check out Quiver Quantitative's $DGX forecast page.

$DGX Price Targets

Multiple analysts have issued price targets for $DGX recently. We have seen 10 analysts offer price targets for $DGX in the last 6 months, with a median target of $217.5.

Here are some recent targets:

  • Ann Hynes from Mizuho set a target price of $235.0 on 02/12/2026
  • Stephanie Davis from Barclays set a target price of $225.0 on 02/11/2026
  • Tycho Peterson from Jefferies set a target price of $220.0 on 02/11/2026
  • David Macdonald from Truist Securities set a target price of $220.0 on 02/11/2026
  • Elizabeth Anderson from Evercore ISI Group set a target price of $220.0 on 02/11/2026
  • Kevin Caliendo from UBS set a target price of $210.0 on 02/11/2026
  • Patrick Donnelly from Citigroup set a target price of $215.0 on 02/10/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles